AbbVie raises as Humira demand holds steady

AbbVie Inc on Thursday raised its 2023 profit forecast on a less-than-feared hit to U.S. sales of arthritis drug Humira from rival biosimilar drugs.... | April 27, 2023

Related Keywords

Bengaluru ,Karnataka ,India ,Sriraj Kalluvila ,Leroy Leo , ,Mariame Sunny ,Abbvie Inc Stock Exchange ,News ,Information ,Press Release ,Abbvie ,Nc ,N ,Hursday ,Aised ,Its ,023 ,Profit ,Forecast ,It ,O ,Sales ,F ,Arthritis ,Drug ,Humira ,Rom ,Rival ,Iosimilar Abbv Us00287y1091 ,